These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35886951)

  • 1. Vasopressin Receptor Type-2 Mediated Signaling in Renal Cell Carcinoma Stimulates Stromal Fibroblast Activation.
    Jamadar A; Dwivedi N; Mathew S; Calvet JP; Thomas SM; Rao R
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the vasopressin type-2 receptor for renal cell carcinoma therapy.
    Sinha S; Dwivedi N; Tao S; Jamadar A; Kakade VR; Neil MO; Weiss RH; Enders J; Calvet JP; Thomas SM; Rao R
    Oncogene; 2020 Feb; 39(6):1231-1245. PubMed ID: 31616061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2-Dependent Mechanism in Polycystic Kidney Disease.
    Dwivedi N; Tao S; Jamadar A; Sinha S; Howard C; Wallace DP; Fields TA; Leask A; Calvet JP; Rao R
    J Am Soc Nephrol; 2020 Aug; 31(8):1697-1710. PubMed ID: 32554753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.
    Takahashi K; Makita N; Manaka K; Hisano M; Akioka Y; Miura K; Takubo N; Iida A; Ueda N; Hashimoto M; Fujita T; Igarashi T; Sekine T; Iiri T
    J Biol Chem; 2012 Jan; 287(3):2099-106. PubMed ID: 22144672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of miR-224-5p by Exosomes from Cancer-Associated Fibroblasts Potentiates Progression of Clear Cell Renal Cell Carcinoma.
    Liu Y; Fu W; Cao X; Li S; Xiong T; Zhang X; Wu X; Cheng L; Wei Y; Gao B
    Comput Math Methods Med; 2021; 2021():5517747. PubMed ID: 34122615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clear cell renal cell carcinoma induces fibroblast-mediated production of stromal periostin.
    Bakhtyar N; Wong N; Kapoor A; Cutz JC; Hill B; Ghert M; Tang D
    Eur J Cancer; 2013 Nov; 49(16):3537-46. PubMed ID: 23896380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors.
    Juul KV; Bichet DG; Nielsen S; Nørgaard JP
    Am J Physiol Renal Physiol; 2014 May; 306(9):F931-40. PubMed ID: 24598801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.
    Cao JJ; Zhao XM; Wang DL; Chen KH; Sheng X; Li WB; Li MC; Liu WJ; He J
    Oncol Rep; 2014 Oct; 32(4):1594-600. PubMed ID: 25175178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti-angiogenic therapy.
    Ambrosetti D; Coutts M; Paoli C; Durand M; Borchiellini D; Montemagno C; Rastoin O; Borderie A; Grepin R; Rioux-Leclercq N; Bernhard JC; Pagès G; Dufies M
    BJU Int; 2022 Jan; 129(1):80-92. PubMed ID: 34107167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation to sustained high plasma vasopressin in water and electrolyte homeostasis in the rat transgenic for the metallothionein-vasopressin fusion gene.
    Yokoi H; Nagasaki H; Tachikawa K; Arima H; Murase T; Miura Y; Hirabayashi M; Oiso Y
    J Endocrinol; 2002 Apr; 173(1):23-33. PubMed ID: 11927381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma.
    Hu W; Su Y; Fei X; Wang X; Zhang G; Su C; Du T; Yang T; Wang G; Tang Z; Zhang J
    Oncol Rep; 2020 Jun; 43(6):1964-1974. PubMed ID: 32236633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
    Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
    Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells.
    Robben JH; Knoers NV; Deen PM
    Mol Biol Cell; 2004 Dec; 15(12):5693-9. PubMed ID: 15469988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin V2 receptor, tolvaptan, and ERK1/2 phosphorylation in the renal collecting duct.
    Khan S; Raghuram V; Chen L; Chou CL; Yang CR; Khundmiri SJ; Knepper MA
    Am J Physiol Renal Physiol; 2024 Jan; 326(1):F57-F68. PubMed ID: 37916285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTPN13 acts as a tumor suppressor in clear cell renal cell carcinoma by inactivating Akt signaling.
    Long Q; Sun J; Lv J; Liang Y; Li H; Li X
    Exp Cell Res; 2020 Nov; 396(1):112286. PubMed ID: 32919955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of microRNA-1274a induces cell apoptosis through regulation of BMPR1B in clear cell renal cell carcinoma.
    Yoshino H; Yonezawa T; Yonemori M; Miyamoto K; Sakaguchi T; Sugita S; Osako Y; Tatarano S; Nakagawa M; Enokida H
    Oncol Rep; 2018 Jan; 39(1):173-181. PubMed ID: 29192325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VRQ397 (CRAVKY): a novel noncompetitive V2 receptor antagonist.
    Rihakova L; Quiniou C; Hamdan FF; Kaul R; Brault S; Hou X; Lahaie I; Sapieha P; Hamel D; Shao Z; Gobeil F; Hardy P; Joyal JS; Nedev H; Duhamel F; Beauregard K; Heveker N; Saragovi HU; Guillon G; Bouvier M; Lubell WD; Chemtob S
    Am J Physiol Regul Integr Comp Physiol; 2009 Oct; 297(4):R1009-18. PubMed ID: 19641130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting a positive regulatory loop in the tumor-macrophage interaction impairs the progression of clear cell renal cell carcinoma.
    Wang C; Wang Y; Hong T; Ye J; Chu C; Zuo L; Zhang J; Cui X
    Cell Death Differ; 2021 Mar; 28(3):932-951. PubMed ID: 33009518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-1 protease-derived soluble (pro)renin receptor targets vasopressin receptor 2 to enhance urine concentrating capability.
    Wang F; Xu C; Luo R; Peng K; Ramkumar N; Xie S; Lu X; Zhao L; Zuo CJ; Kohan DE; Yang T
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.